Irras Ab News - 0GDW

IRRAS AB publishes Year End Report for the period January to December 2022

IRRAS AB publishes Year End Report for the period January to December 2022 PR Newswire STOCKHOLM, Feb. 16, 2023 Commercial partnership underway...

IRRAS AB publishes Year End Report for the period January to December 2022

IRRAS AB publishes Year End Report for the period January to December 2022 PR Newswire STOCKHOLM, Feb. 16, 2023 Commercial partnership underway...

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head...

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head...

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit PR Newswire STOCKHOLM, Dec. 12, 2022 IRRAS received US FDA...

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit PR Newswire STOCKHOLM, Dec. 12, 2022 IRRAS received US FDA...

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System PR Newswire STOCKHOLM, Nov. 14, 2022 IRRAS...

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System PR Newswire STOCKHOLM, Nov. 14, 2022 IRRAS...

IRRAS AB publishes Interim Report for the period January to September 2022

IRRAS AB publishes Interim Report for the period January to September 2022 PR Newswire STOCKHOLM, Nov. 10, 2022 STOCKHOLM, Nov. 10, 2022...

IRRAS AB publishes Interim Report for the period January to September 2022

IRRAS AB publishes Interim Report for the period January to September 2022 PR Newswire STOCKHOLM, Nov. 10, 2022 STOCKHOLM, Nov. 10, 2022...

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery PR Newswire STOCKHOLM, Oct. 13, 2022 The 22nd...

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery PR Newswire STOCKHOLM, Oct. 13, 2022 The 22nd...

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of...

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of...

IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences

IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences PR Newswire STOCKHOLM, Oct. 5, 2022 IRRAS will...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Irras Ab (0GDW)

Professional-Grade Tools, for Individual Investors.

0GDW News

IRRAS AB publishes Year End Report for the period January to December 2022

IRRAS AB publishes Year End Report for the period January to December 2022

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

IRRAS AB publishes Interim Report for the period January to September 2022

IRRAS AB publishes Interim Report for the period January to September 2022

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences

0GDW Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Irras Ab (0GDW) News

Irras Ab (0GDW)

Professional-Grade Tools, for Individual Investors.

0GDW News

IRRAS AB publishes Year End Report for the period January to December 2022

IRRAS AB publishes Year End Report for the period January to December 2022

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

IRRAS AB publishes Interim Report for the period January to September 2022

IRRAS AB publishes Interim Report for the period January to September 2022

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences

0GDW Discussion

Your Recent History